Susheel Kodali, Rebecca T Hahn, Raj Makkar, Moody Makar, Charles J Davidson, Jyothy J Puthumana, Firas Zahr, Scott Chadderdon, Neil Fam, Geraldine Ong, Pradeep Yadav, Vinod Thourani, Mani A Vannan, William W O'Neill, Dee Dee Wang, Didier Tchétché, Nicolas Dumonteil, Laurent Bonfils, Laurent Lepage, Robert Smith, Paul A Grayburn, Rahul P Sharma, Christiane Haeffele, Vasilis Babaliaros, Patrick T Gleason, Sammy Elmariah, Ignacio Inglessis-Azuaje, Jonathan Passeri, Howard C Herrmann, Frank E Silvestry, Scott Lim, Dale Fowler, John G Webb, Robert Moss, Thomas Modine, Stephane Lafitte, Azeem Latib, Edwin Ho, Ythan Goldberg, Pinak Shah, Charles Nyman, Josep Rodés-Cabau, Elisabeth Bédard, Nicolas Brugger, Anna Sannino, Michael J Mack, Martin B Leon, Stephan Windecker
BACKGROUND AND AIMS: For patients with symptomatic, severe tricuspid regurgitation (TR), early results of transcatheter tricuspid valve (TV) intervention studies have shown significant improvements in functional status and quality of life associated with right-heart reverse remodelling. Longer-term follow-up is needed to confirm sustained improvements in these outcomes. METHODS: The prospective, single-arm, multicentre TRISCEND study enrolled 176 patients to evaluate the safety and performance of transcatheter TV replacement in patients with ≥moderate, symptomatic TR despite medical therapy...
December 7, 2023: European Heart Journal